{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:27:22Z","timestamp":1768814842261,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00198-015-3116-z","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T10:43:24Z","timestamp":1431081804000},"page":"2131-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial"],"prefix":"10.1007","volume":"26","author":[{"given":"A. D.","family":"Cizmic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M. F.","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Milchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. S.","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Billups","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"3116_CR1","unstructured":"National Osteoporosis Foundation (2013) What is osteoporosis? http:\/\/www.nof.org\/articles\/7 . Accessed 9 Sep 2013"},{"issue":"9041","key":"3116_CR2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348(9041):1535\u20131541","journal-title":"Lancet"},{"key":"3116_CR3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/archinte.163.17.2052","volume":"163","author":"SE Andrade","year":"2003","unstructured":"Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052\u20132057","journal-title":"Arch Intern Med"},{"issue":"11","key":"3116_CR4","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11606-008-0772-0","volume":"23","author":"RA Yood","year":"2008","unstructured":"Yood RA, Mazar KM, Andrade SE, Emani S, Chan W, Kahler KH (2008) Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 23(11):1815\u20131821","journal-title":"J Gen Intern Med"},{"key":"3116_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1185\/03007990903550586","volume":"26","author":"AS Gadkari","year":"2010","unstructured":"Gadkari AS, McHorney CA (2010) Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin 26:683\u2013705","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"3116_CR6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/jgs.12521","volume":"61","author":"KN Hogan","year":"2013","unstructured":"Hogan KN, Milchak JL, Heilmann RMF, Billups SJ, Delate T (2013) Evaluation of primary nonadherence to oral bisphosphonate therapy. J Am Geriatr Soc 61(11):2046\u20132047","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"3116_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/2013.jamainternmed.717","volume":"173","author":"SF Derose","year":"2013","unstructured":"Derose SF, Green K, Marrett E, Tunceli K, Cheetham TC, Chiu VY, Harrison TN, Reynolds K, Vansomphone SS, Scott RD (2013) Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med 173(1):38\u201343","journal-title":"JAMA Intern Med"},{"key":"3116_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2474-12-92","volume":"12","author":"JE Sale","year":"2011","unstructured":"Sale JE, Gignac MA, Hawker G, Frankel L, Beaton D, Bogoch E, Elliot-Gibson V (2011) Decision to take osteoporosis medication in patients who have had a fracture and are \u2018high\u2019 risk for future fracture: a qualitative study. BMC Musculoskelet Disord 12:92","journal-title":"BMC Musculoskelet Disord"},{"key":"3116_CR9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00198-009-1141-5","volume":"21","author":"JT Schousboe","year":"2010","unstructured":"Schousboe JT, Dowd BE, Davison ML, Kane RL (2010) Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int 21:1899\u20131909","journal-title":"Osteoporos Int"},{"key":"3116_CR10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-007-0466-1","volume":"19","author":"FJA Penning-van Beest","year":"2008","unstructured":"Penning-van Beest FJA, Erkens JA, Olson M, Herings RMC (2008) Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int 19:511\u2013517","journal-title":"Osteoporos Int"},{"key":"3116_CR11","first-page":"127","volume":"6","author":"SD Fenerty","year":"2012","unstructured":"Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR (2012) The effect of reminder systems on patients\u2019 adherence to treatment. Patient Prefer Adherence 6:127\u2013135","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"3116_CR12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"PD Delmas","year":"2007","unstructured":"Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD, Grauer A, Cahall D, Watts NB, Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92(4):1296\u20131304","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3116_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"JA Clowes","year":"2004","unstructured":"Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89(3):1117\u20131123","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3116_CR14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","volume":"21","author":"JA Cramer","year":"2005","unstructured":"Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21(9):1453\u20131460","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"3116_CR15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","volume":"80","author":"RR Recker","year":"2005","unstructured":"Recker RR, Gallagher R, MacCosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80(7):856\u2013861","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"3116_CR16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1475-6773.2009.00989.x","volume":"44","author":"AJ Karter","year":"2009","unstructured":"Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV (2009) New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 44(5):1640\u20131661","journal-title":"Health Serv Res"},{"issue":"2","key":"3116_CR17","first-page":"111","volume":"2","author":"JN Liberman","year":"2010","unstructured":"Liberman JN, Hutchins DS, Popiel RG, Patel MH, Jan SA, Berger JE (2010) Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. Am J Pharm Benefits 2(2):111\u2013118","journal-title":"Am J Pharm Benefits"},{"issue":"11","key":"3116_CR18","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29(11):2520\u20132526","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3116-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:22Z","timestamp":1558624522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3116-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}